Scottsdale, Arizona 85251

  • Migraine

Purpose:

The goal of this study is to compare the efficacy and adverse events of inhaled isopropyl alcohol vapor (IAV) versus placebo (inhaled eucalyptus scent (IES) (1:20 dilution in mineral oil) for treating nausea associated with acute migraine attacks.


Study summary:

The main goal of this study is to examine the efficacy of (nausea reduction and time to use of other anti-nausea medications) and side effects of inhaled isopropyl alcohol vapor (IAV) for treating nausea among migraine patients using a double blind randomized control methodology. IAV is being compared inhaled eucalyptus scent (IES) (1:20 dilution in mineral oil) which has not shown benefit for treating nausea or migraine and is therefore considered placebo in this study.


Criteria:

Inclusion Criteria: - Patients 18 to 65 years old with nausea associated migraines at least twice per month Exclusion Criteria: - Patients <18 or >65 years old - Patients without a diagnosis of acute migraine


NCT ID:

NCT05175521


Primary Contact:

Principal Investigator
Jill Rau, MD, PhD
HonorHealth Research Institute

Angelina Cooper
Phone: 480-583-3193
Email: ancooper@honorhealth.com


Backup Contact:

N/A


Location Contact:

Scottsdale, Arizona 85251
United States

Angelina Cooper
Phone: 480-583-3193
Email: ancooper@honorhealth.com

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: October 02, 2022

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.